SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/C92270110EFBF4F489C2B76E44A890C46B0370C1D6207C19ACB4FCC30814F44677A429BB4CA59C718E8B4C0B47418561>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/C92270110EFBF4F489C2B76E44A890C46B0370C1D6207C19ACB4FCC30814F44677A429BB4CA59C718E8B4C0B47418561
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C92270110EFBF4F489C2B76E44A890C46B0370C1D6207C19ACB4FCC30814F44677A429BB4CA59C718E8B4C0B47418561
http://www.w3.org/2000/01/rdf-schema#comment
"SYK together with phospholipase Cgamma2 may serve as potential biomarkers to predict dasatinib therapeutic response in patients."
xsd:string
http://purl.uniprot.org/uniprot/#_0AD24FF5B3C590A31EC087063052DA66019632DD3DEF5C8C313B4F5BBB1C0E13FF40F3A5C998DECEBFEA880C3F17E676
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/C92270110EFBF4F489C2B76E44A890C46B0370C1D6207C19ACB4FCC30814F44677A429BB4CA59C718E8B4C0B47418561
http://purl.uniprot.org/uniprot/H3BPZ3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C92270110EFBF4F489C2B76E44A890C46B0370C1D6207C19ACB4FCC30814F44677A429BB4CA59C718E8B4C0B47418561
http://purl.uniprot.org/uniprot/#_H3BPZ3-mappedCitation-20068106
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C92270110EFBF4F489C2B76E44A890C46B0370C1D6207C19ACB4FCC30814F44677A429BB4CA59C718E8B4C0B47418561